Agency staff expressed uncertainty over whether PFS benefit was "clinically meaningful" ...

Clinical development strategy includes an mCRPC-dedicated Phase 1b trial in PLUVICTO®-naïve and -experienced patients, and a ...

A new study designs drugs that bind to intrinsically disordered proteins that are extremely difficult to target due to their flexible nature.

Up to 85 percent of prostate cancers are diagnosed in the early stages, when they are still curable.Even when diagnosed at an advanced stage, most prostate cancers respond well to treatment. The first ...

A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly longer without disease progression when they received a ...

Researchers at the University of Illinois Chicago have developed an anti-cancer therapy inspired by bacteria found in cancer ...

Sonablate, a medical technology company focused on non-invasive prostate cancer treatment using high-intensity focused ultrasound (HIFU) , today announced the appointment of Brad Saar, former ...

Israeli Prime Minister Benjamin Netanyahu said he had received successful treatment for early-stage prostate cancer.